Search results

|title=Tretter L, Patocs A, Chinopoulos C (2016) Succinate, an intermediate in metabolism, signal tran |authors=Tretter L, Patocs A, Chinopoulos C

...Igaz P, Doczi J, Luconi M, Chinopoulos C, Patocs A (2020) Glutaminases as a novel target for SDHB-associated pheochromocytomas/paragangliomas. Cancers ...ber Z, Butz H, Darvasi O, Igaz P, Doczi J, Luconi M, Chinopoulos C, Patocs A

...o Z, Araki M, Araki K, Nakahara M, Ito H, Gál A, Molnár MJ, Nagy Z, Patocs A, Adam-Vizi V, Chinopoulos C (2016) Two transgenic mouse models for β-subun ...o Z, Araki M, Araki K, Nakahara M, Ito H, Gal A, Molnár MJ, Nagy Z, Patocs A, Adam-Vizi V, Chinopoulos C

|authors=Bastos Sant'Anna Silva AC, Klocker H, Weber A, Elmer E, Meszaros AT, Gnaiger E ...the study. To assess succinate utilization in intact cells independent of a plasma membrane succinate transporter, we applied novel plasma membrane-per

...e, particularly poor food habits linked to high-fat diets, are regarded as a leading cause for the present trend [2], but the biochemical link between d ...ng the experiment. Metabolic stress tests (IPGTT and IPITT) were performed a week before sacrifice. After sacrifice, several tissues were collected and

:::# Tretter LA, Patocs A, Chinopoulos C (2016) Succinate, an intermediate in metabolism, signal tran ...Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord EN, Smith AC, Eyassu F, Shirley R, Hu CH, Dare AJ, James

...PHOS remodeling in high-grade prostate cancer involves mtDNA mutations and a prognostic gene expression signature. https://doi.org/10.26124/mitofit:1900 ...PHOS remodeling in high-grade prostate cancer involves mtDNA mutations and a prognostic gene expression signature]'''